Zobrazeno 1 - 10
of 96
pro vyhledávání: '"P.W. Durbin"'
Publikováno v:
Radiation Protection Dosimetry. 79:433-443
Chelation therapy for internally deposited actinides has been shown to reduce acute radiation damage and chemical toxicity and the severity of late radiation effects. This review traces the development of chelating agents for the actinides from the i
Autor:
R. Burgada, Kenneth N. Raymond, M.J. Pearce, J.C. Moody, I. Wilson, G.N. Stradling, P.W. Durbin, S.A. Gray
Publikováno v:
Radiation Protection Dosimetry. 53:319-322
The comparative efficacies of treatment with 3,4,3-LIHOPO and DTPA have been investigated in the rat after their subcutaneous and intramuscular injection. Commencement of treatment was delayed 30 min, 6 h or 1 d and the animals killed at 7 d. Under a
Publikováno v:
Radiation Protection Dosimetry. 53:305-309
Autor:
T. Bailly, J. L. Poncy, Y. Leroux, R. Burgada, Roland Masse, François Paquet, P.W. Durbin, G. Rateau, Kenneth N. Raymond
Publikováno v:
Radiation Protection Dosimetry. 53:323-326
The ability of 3,4,3-LIHOPO, used at a dosage of 3 μmol.kg −1 of body weight, has been tested in Sprague-Dawley rats for reducing the retention of plutonium after inhalation of 238 Pu-TBP. The comparison was made with DTPA, the reference substance
Autor:
Y. Leroux, J.C. Moody, S.A. Gray, G.N. Stradling, K.N. Raymond, P.W. Durbin, I. Wilson, R. Burgada, M.J. Pearce, T. Bailly
Publikováno v:
International Journal of Radiation Biology. 64:133-140
With DTPA as a comparison, the siderophore analogue 3,4,3-LIHOPO has been examined for its ability to remove 238Pu and 241Am from the rat after subcutaneous (s.c.) and intramuscular (i.m.) injection of about 200 Bq of each actinide (0.3 ng Pu, 1.6 ng
Autor:
G.N. Stradling, S.A. Gray, M. Ellender, J.C. Moody, A. Hodgson, M. Pearce, I. Wilson, R. Burgada, T. Bailly, Y.G.P. Leroux, D. El Manouni, K.N. Raymond, P.W. Durbin
Publikováno v:
International Journal of Radiation Biology. 62:487-497
With DTPA as a comparison, the siderophore analogue code named 3,4,3-LIHOPO has been tested for its ability to remove 238Pu and 241Am from rats after their inhalation or intravenous injection as nitrate. The most effective treatment regimen for inhal
Autor:
G.N. Stradling, J.C. Moody, A. Hodgson, P.W. Durbin, S.A. Gray, S.J. Rodgers, P.N. Turowski, D.L. White, Kenneth N. Raymond
Publikováno v:
International Journal of Radiation Biology. 59:1269-1277
A hydroxypridinone derivative of desferrioxamine (Na-DFO-HOPO), a dihydroxamic derivative of diethylenetriaminepenta-acetic acid (ZnNa-DTPA-DX), and DTPA (CaNa3- and ZnNa3-DTPA) were tested at dosages of 30 mumol kg-1 for their ability to remove 238P
Autor:
T. Bailly, P.W. Durbin, R. Burgada, Jide Xu, M.-H. Hengé-Napoli, Kenneth N. Raymond, Birgitta Kullgren
Publikováno v:
Radiation protection dosimetry. 105(1-4)
Linear octadentate spermine based 3,4,3-LI(1,2-HOPO) and the mixed ligand, 3,4,3-LI(1,2-Me-3,2-HOPO), are the most effective agents for decorporation of Pu prepared so far; they are effective at low dosage, orally active, and of low toxicity at effec
Autor:
M. J. Inskip, C. A. Franklin, C. L. Baccanale, William I. Manton, P.W. Durbin, Ellen J. O'Flaherty
Publikováno v:
Toxicology and applied pharmacology. 149(1)
Endogenous (predominantly bone) and exogenous lead were differentially labeled in two 11-year-old female cynomolgus monkeys (Macaca fascicularis) to establish the contributions of the two sources to blood lead. The monkeys had been administered a com
Publikováno v:
Humanexperimental toxicology. 15(4)
Nine new octadentate ligands based on cyclic, spermine (3,4,3-LI), desferrioxamine (DFO), or H-shaped tetrakis amine (penten) molecular backbones were prepared containing catecholamide (CAM), carboxycatecholamide (CAM(C)), or terephthalamide (TAM) ch